Menu
  • Home
  • About
    • Board and Management Team
    • Quality Assured Service Delivery
    • Contact Us
  • Products
    • FerriScan - MRI Measurement of Liver Iron Concentration
    • Cardiac T2* with FerriScan
    • HepaFat-Scan - MRI Measurement of Liver Fat
    • Bone Marrow R2-MRI
    • MRI Phantoms
  • Resources
  • Reimbursement
  • Clinical Trial Services
  • Investors
    • Business Overview
    • Board and Management Team
    • Share Price
    • ASX Announcements
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
      • 2004
    • ASX subscribe
    • Annual Reports
    • Analyst Coverage
  • News
    • Latest News
    • News Subscribe
    • Events
  • Contact
  • FAST Login
  • Easy Setup
  • Find a Centre
  • SMART Portal
  • Home
  • About
    • Board and Management Team
    • Quality Assured Service Delivery
    • Contact Us
  • Products
    • FerriScan - MRI Measurement of Liver Iron Concentration
    • Cardiac T2* with FerriScan
    • HepaFat-Scan - MRI Measurement of Liver Fat
    • Bone Marrow R2-MRI
    • MRI Phantoms
  • Resources
  • Reimbursement
  • Clinical Trial Services
  • Investors
    • Business Overview
    • Board and Management Team
    • Share Price
    • ASX Announcements
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
      • 2004
    • ASX subscribe
    • Annual Reports
    • Analyst Coverage
  • News
    • Latest News
    • News Subscribe
    • Events
  • Contact
Home | Investors | ASX Announcements | 2022

ASX Announcements 2022

Date Document
02/05/2022 Quarterly Activities/Appendix 4C Cash Flow Report
29/04/2022 Company Secretary Appointment/Resignation
06/04/2022 Investor Presentation April 2022
05/04/2022 Platform Integration & Partnership Agreement with CARPL.ai
28/02/2022 Half Yearly Report and Accounts
07/02/2022 US CPT Code Confirmation for LiverSmart
31/01/2022 Quarterly Activities/Appendix 4C Cash Flow Report
27/01/2022 Resonance Health Enters China - Pharma Contract Signed
25/01/2022 Resonance Health Contracted for Third Party Clinical Trial
18/01/2022 Change in substantial holding

Investors

  • Business Overview
  • Board and Management Team
  • Share Price
  • ASX Announcements
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
  • ASX subscribe
  • Annual Reports
  • Analyst Coverage
  • Twitter
  • LinkedIn
  • Search
  • © 2018 Resonance Health
  • Disclaimer
  • Privacy
  • Sitemap
Website by ChooseDigital.com.au